Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2023 Filed Oct 2, 2023 22:51 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionCommon Stock | 29,350 | $36.75 | $1,078,612.50 |
DisclosureSEC source: 0001225208-23-009136 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,835.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 20:49 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,255 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-009087 · doc4.xml · derivative · entry 4 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,780 Underlying: Common Stock · 7,255 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 20:49 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 7,255 | $69.54 | $504,527.21 |
DisclosureSEC source: 0001225208-23-009087 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,248 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $69.21 to $70.08. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 29, 2023 Filed Sep 29, 2023 20:49 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,255 | $36.75 | $266,621.25 |
DisclosureSEC source: 0001225208-23-009087 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 00:00 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 4,500 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008937 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 4,500 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 00:00 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 4,500 | $73.71 | $331,695.00 |
DisclosureSEC source: 0001225208-23-008937 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,502.6931 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 00:00 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 4,500 | $36.75 | $165,375.00 |
DisclosureSEC source: 0001225208-23-008937 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,002.6931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 00:00 UTC |
Wood Larry LGlobal President TAVR & Surg
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 8,660 | $0.00 Strike: $45.28 | $0.00 |
DisclosureSEC source: 0001225208-23-008936 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,978 Underlying: Common Stock · 8,660 shares Expires 2025-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 00:00 UTC |
Wood Larry LGlobal President TAVR & Surg
|
SaleCommon Stock | 8,660 | $73.63 | $637,615.02 |
DisclosureSEC source: 0001225208-23-008936 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,793.7137 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $73.23 to $73.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 00:00 UTC |
Wood Larry LGlobal President TAVR & Surg
|
Exercise / conversionCommon Stock | 8,660 | $45.28 | $392,096.22 |
DisclosureSEC source: 0001225208-23-008936 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,453.7137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 21:01 UTC |
Markowitz WayneGM & SVP, Surgical
|
GrantEmployee Stock Option (Right to Acquire) · Derivative | 19,256 | $0.00 Strike: $74.02 | $0.00 |
DisclosureSEC source: 0001225208-23-008962 · doc4.xml · derivative · entry 2 Markowitz Wayne · CIK 0001991414 · GM & SVP, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,256 Underlying: Common Stock · 19,256 shares Expires 2030-09-13 F2 · derivative.exercise_date: These options were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable annually in equal installments over a period of four years commencing one year after the grant date. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 21:01 UTC |
Markowitz WayneGM & SVP, Surgical
|
GrantCommon Stock | 7,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008962 · doc4.xml · nonDerivative · entry 1 Markowitz Wayne · CIK 0001991414 · GM & SVP, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,262 F1 · shares: These restricted stock units were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested annually in equal installments over a period of four years commencing one year after the grant date. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 21:29 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008819 · doc4.xml · derivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 5,000 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 21:29 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 5,000 | $76.00 | $380,000.00 |
DisclosureSEC source: 0001225208-23-008819 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,813.571 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 21:29 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 5,000 | $36.75 | $183,750.00 |
DisclosureSEC source: 0001225208-23-008819 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,813.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 21:09 UTC |
Chopra DaveenCVP, TMTT
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 8,500 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-23-008737 · doc4.xml · derivative · entry 3 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 8,500 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 21:09 UTC |
Chopra DaveenCVP, TMTT
|
SaleCommon Stock | 8,500 | $76.07 | $646,609.45 |
DisclosureSEC source: 0001225208-23-008737 · doc4.xml · nonDerivative · entry 2 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,950 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $75.83 to $76.42. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 21:09 UTC |
Chopra DaveenCVP, TMTT
|
Exercise / conversionCommon Stock | 8,500 | $59.26 | $503,681.95 |
DisclosureSEC source: 0001225208-23-008737 · doc4.xml · nonDerivative · entry 1 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023. Read SEC document |
| September 05, 2023 Filed Sep 5, 2023 23:08 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 29,350 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008709 · doc4.xml · derivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,800 Underlying: Common Stock · 29,350 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2023 Filed Sep 5, 2023 23:08 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 29,350 | $75.86 | $2,226,491.00 |
DisclosureSEC source: 0001225208-23-008709 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,485.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $75.40 to $76.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 05, 2023 Filed Sep 5, 2023 23:08 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionCommon Stock | 29,350 | $36.75 | $1,078,612.50 |
DisclosureSEC source: 0001225208-23-008709 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,835.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. Read SEC document |
| August 31, 2023 Filed Aug 31, 2023 21:34 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,255 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008596 · doc4.xml · derivative · entry 4 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,035 Underlying: Common Stock · 7,255 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2023 Filed Aug 31, 2023 21:34 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 7,255 | $77.79 | $564,366.45 |
DisclosureSEC source: 0001225208-23-008596 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,248 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| August 31, 2023 Filed Aug 31, 2023 21:34 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,255 | $36.75 | $266,621.25 |
DisclosureSEC source: 0001225208-23-008596 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| August 31, 2023 Filed Aug 31, 2023 21:34 UTC |
MUSSALLEM MICHAEL ADirector
|
GiftCommon Stock | 49,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008597 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 3,666,688 Read SEC document |
| August 31, 2023 Filed Aug 31, 2023 21:34 UTC |
MUSSALLEM MICHAEL ADirector
|
GiftCommon Stock | 49,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008597 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,485.82 Read SEC document |
| August 29, 2023 Filed Aug 29, 2023 21:31 UTC |
Chopra DaveenCVP, TMTT
|
SaleCommon Stock | 1,500 | $76.69 | $115,040.40 |
DisclosureSEC source: 0001225208-23-008545 · doc4.xml · nonDerivative · entry 1 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,950 F1 · price: This transaction was executed in multiple trades at prices ranging from $76.690 to $76.701. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 4,500 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008220 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,500 Underlying: Common Stock · 4,500 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 4,500 | $79.30 | $356,850.00 |
DisclosureSEC source: 0001225208-23-008220 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,502.6931 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 4,500 | $36.75 | $165,375.00 |
DisclosureSEC source: 0001225208-23-008220 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,002.6931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:02 UTC |
Wood Larry LGlobal President TAVR & Surg
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,421 | $0.00 Strike: $45.28 | $0.00 |
DisclosureSEC source: 0001225208-23-008219 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,638 Underlying: Common Stock · 6,421 shares Expires 2025-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:02 UTC |
Wood Larry LGlobal President TAVR & Surg
|
SaleCommon Stock | 6,421 | $79.30 | $509,185.30 |
DisclosureSEC source: 0001225208-23-008219 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,793.7137 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023. Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 22:02 UTC |
Wood Larry LGlobal President TAVR & Surg
|
Exercise / conversionCommon Stock | 6,421 | $45.28 | $290,721.69 |
DisclosureSEC source: 0001225208-23-008219 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,214.7137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023. Read SEC document |
| August 10, 2023 Filed Aug 10, 2023 21:48 UTC |
STONE HEISZ LESLIEDirector
|
SaleCommon Stock | 3,303 | $78.87 | $260,508.60 |
DisclosureSEC source: 0001225208-23-008187 · doc4.xml · nonDerivative · entry 1 STONE HEISZ LESLIE · CIK 0001235408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,980 Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 21:44 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 5,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008138 · doc4.xml · derivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 5,000 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 21:44 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 5,000 | $78.64 | $393,185.00 |
DisclosureSEC source: 0001225208-23-008138 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,813.571 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $78.44 to $78.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2023 Filed Aug 9, 2023 21:44 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 5,000 | $36.75 | $183,750.00 |
DisclosureSEC source: 0001225208-23-008138 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,813.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023. Read SEC document |
| August 07, 2023 Filed Aug 7, 2023 23:20 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 29,350 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-008065 · doc4.xml · derivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,150 Underlying: Common Stock · 29,350 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2023 Filed Aug 7, 2023 23:20 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 29,050 | $79.86 | $2,319,933.00 |
DisclosureSEC source: 0001225208-23-008065 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,251.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $79.490 to $80.485. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2023 Filed Aug 7, 2023 23:20 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 300 | $80.54 | $24,162.00 |
DisclosureSEC source: 0001225208-23-008065 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,301.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.510 to $80.570. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2023 Filed Aug 7, 2023 23:20 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionCommon Stock | 29,350 | $36.75 | $1,078,612.50 |
DisclosureSEC source: 0001225208-23-008065 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,601.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. Read SEC document |
| July 31, 2023 Filed Jul 31, 2023 21:23 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,255 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-007787 · doc4.xml · derivative · entry 4 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,290 Underlying: Common Stock · 7,255 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Jul 31, 2023 21:23 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 7,255 | $84.35 | $611,959.25 |
DisclosureSEC source: 0001225208-23-007787 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,248 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| July 31, 2023 Filed Jul 31, 2023 21:23 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,255 | $36.75 | $266,621.25 |
DisclosureSEC source: 0001225208-23-007787 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 22:33 UTC |
Zovighian Bernard JDirector · CEO
|
OtherCommon Stock | 2,558.6207 | $83.54 | $213,744.36 |
DisclosureSEC source: 0001225208-23-007850 · doc4.xml · nonDerivative · entry 1 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,111.4942 F1 · price: The exact unit price to its last decimal number is $83.538983. Read SEC document |
| July 14, 2023 Filed Jul 14, 2023 21:58 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 3,500 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-007512 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 3,500 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 14, 2023 21:58 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 3,500 | $92.94 | $325,275.30 |
DisclosureSEC source: 0001225208-23-007512 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,502.6931 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $92.68 to $93.26 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 14, 2023 Filed Jul 14, 2023 21:58 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 3,500 | $36.75 | $128,625.00 |
DisclosureSEC source: 0001225208-23-007512 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,002.6931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| July 14, 2023 Filed Jul 14, 2023 21:58 UTC |
Wood Larry LGlobal President TAVR & Surg
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 8,660 | $0.00 Strike: $45.28 | $0.00 |
DisclosureSEC source: 0001225208-23-007511 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,059 Underlying: Common Stock · 8,660 shares Expires 2025-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2023 Filed Jul 14, 2023 21:58 UTC |
Wood Larry LGlobal President TAVR & Surg
|
SaleCommon Stock | 8,660 | $92.94 | $804,843.08 |
DisclosureSEC source: 0001225208-23-007511 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,793.7137 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $92.68 to $93.24 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.